GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » Institutional Ownership

Bionomics (Bionomics) Institutional Ownership : 0.06% (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bionomics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bionomics's institutional ownership is 0.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bionomics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bionomics's Float Percentage Of Total Shares Outstanding is 77.39%.

Bionomics Institutional Ownership Historical Data

The historical data trend for Bionomics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics Institutional Ownership Chart

Bionomics Historical Data

The historical data trend for Bionomics can be seen below:

2022-02-28 2022-03-31 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28
Institutional Ownership 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06

Bionomics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Bionomics (Bionomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » Institutional Ownership
Comparable Companies
XTER:T5O XTER:MDG1 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB ALNY BGNE BMRN RPRX SRPT SHSE:603392 SZSE:300122
Traded in Other Exchanges
B1N0:Germany
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Website
https://www.bionomics.com.au
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.